Murty V V, Mitra A B, Luthra U K, Singh I P
Hum Genet. 1986 Jan;72(1):37-42. doi: 10.1007/BF00278815.
The frequency of sister chromatid exchanges (SCEs) was studied in leucocytes from 46 patients with cervical carcinoma, 89 precancerous lesions, and 43 age-matched control women. The frequency of SCEs was found to be 10.15 +/- 2.49 in cancer, 8.83 +/- 2.15 in precancerous lesions, and 7.55 +/- 2.24 in controls. The analyses of SCE data revealed a highly significant (P less than 0.001) increase in precancerous and cancerous lesions compared to controls. The intra-chromosomal distribution of SCEs revealed a random increase in various chromosomal groups in patients with cancer and dysplasia compared to controls. The mean SCE level among various groups of precancerous lesions according to severity of pathological condition did not show significant differences. However, 70.8% of dysplasia cases revealed SCE levels higher than the average in controls. The increased frequencies of SCEs in the majority of cancer patients and a few precancerous lesions indicate that individuals with high SCE levels may be at a high risk of developing cancer. Thus the usefulness of SCE levels as a preclinical marker to identify the high risk group of dysplasias needs to be ascertained by follow-up studies; these are in progress.
对46例宫颈癌患者、89例癌前病变患者及43例年龄匹配的对照女性的白细胞进行姐妹染色单体交换(SCE)频率研究。结果发现,癌症患者的SCE频率为10.15±2.49,癌前病变患者为8.83±2.15,对照女性为7.55±2.24。SCE数据分析显示,与对照组相比,癌前病变和癌症患者的SCE频率显著升高(P<0.001)。SCE的染色体内部分布显示,与对照组相比,癌症和发育异常患者的不同染色体组中SCE随机增加。根据病理状况严重程度划分的不同癌前病变组之间的平均SCE水平未显示出显著差异。然而,70.8%的发育异常病例显示SCE水平高于对照组平均水平。大多数癌症患者和少数癌前病变患者的SCE频率增加表明,SCE水平高的个体患癌风险可能较高。因此,SCE水平作为识别发育异常高危组的临床前标志物的有用性需要通过后续研究来确定;这些研究正在进行中。